Moyamoya disease: current concepts and future perspectives

S Kuroda, K Houkin - The Lancet Neurology, 2008 - thelancet.com
Moyamoya disease is an uncommon cerebrovascular disease that is characterised by
progressive stenosis of the terminal portion of the internal carotid artery and its main …

[HTML][HTML] Moyamoya disease: treatment and outcomes

T Kim, CW Oh, JS Bang, JE Kim, WS Cho - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the
effectiveness of surgical revascularization in preventing stroke has been addressed by many …

2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society

M Fujimura, T Tominaga, S Kuroda… - Neurologia medico …, 2022 - jstage.jst.go.jp
1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo,
Hokkaido, Japan 2Department of Neurosurgery, Tohoku University Graduate School of …

Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)

RC on the Pathology - Neurologia medico-chirurgica, 2012 - pubmed.ncbi.nlm.nih.gov
Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the
circle of Willis) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous …

Adult Moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association/American Stroke …

NR Gonzalez, S Amin-Hanjani, OY Bang, C Coffey… - Stroke, 2023 - Am Heart Assoc
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and
mortality. A writing group of experts was selected to conduct a literature search, summarize …

Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative …

M Fujimura, H Shimizu, T Inoue, S Mugikura… - …, 2011 - journals.lww.com
BACKGROUND: Superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis
prevents cerebral ischemic attack by improving cerebral blood flow in patients with occlusive …

Moyamoya disease

M Fujimura, OY Bang, JS Kim - … : Pathophysiology, Diagnosis and …, 2016 - karger.com
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by
progressive stenosis at the terminal portion of the internal carotid artery and an abnormal …

Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron …

H Uchino, S Kuroda, K Hirata, T Shiga, K Houkin… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Clinical features and pathophysiology of postoperative
hyperperfusion in moyamoya disease are still unclear. This study was aimed to clarify the …

Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya …

M Fujimura, S Mugikura, T Kaneta, H Shimizu… - Surgical neurology, 2009 - Elsevier
BACKGROUND: Superficial temporal artery-middle cerebral artery anastomosis for
moyamoya disease prevents cerebral ischemic attack by improving CBF, whereas recent …

[HTML][HTML] Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene

M Fujimura, S Sonobe, Y Nishijima, K Niizuma… - Journal of …, 2014 - ncbi.nlm.nih.gov
Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the
internal carotid artery and an abnormal vascular network at the base of the brain. Although …